Bladder cancer breakthrough? MRI may predict chemo success in days
NCT ID NCT07202845
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether a special type of MRI (multiparametric MRI) can predict early on if chemotherapy is working for muscle-invasive bladder cancer. 39 participants will get three MRI scans: before chemo, one day after the first dose, and after finishing chemo. The goal is to see if changes in the MRI can tell doctors whether the tumor is shrinking, helping avoid unnecessary delays and toxicity from ineffective treatment.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Multiparametric Magnetic Resonance Imaging (mpMRI)
What this could lead to
If successful, this could allow doctors to quickly tell if chemotherapy is working for bladder cancer patients, enabling them to switch treatments sooner and avoid unnecessary side effects.
What could go wrong
This is a small, early study with only 39 participants, so results may not apply to everyone. The MRI technique is still experimental and not yet proven to reliably predict outcomes.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MIBC are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Amr E. Darwish
RECRUITINGAsyut, Egypt
Contact Phone: •••-•••-•••• Email: •••••@•••••